These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 26899498
1. A beacon of hope in stroke therapy-Blockade of pathologically activated cellular events in excitotoxic neuronal death as potential neuroprotective strategies. Hoque A, Hossain MI, Ameen SS, Ang CS, Williamson N, Ng DC, Chueh AC, Roulston C, Cheng HC. Pharmacol Ther; 2016 Apr; 160():159-79. PubMed ID: 26899498 [Abstract] [Full Text] [Related]
2. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. Lipton SA. J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416 [Abstract] [Full Text] [Related]
8. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders. Lipton SA, Gu Z, Nakamura T. Int Rev Neurobiol; 2007 Dec; 82():1-27. PubMed ID: 17678953 [Abstract] [Full Text] [Related]
9. Neuroprotective and anti-inflammatory roles of the phosphatase and tensin homolog deleted on chromosome Ten (PTEN) Inhibition in a Mouse Model of Temporal Lobe Epilepsy. Grande V, Manassero G, Vercelli A. PLoS One; 2014 Dec; 9(12):e114554. PubMed ID: 25501575 [Abstract] [Full Text] [Related]
10. Memantine for the Treatment of Dementia: A Review on its Current and Future Applications. Folch J, Busquets O, Ettcheto M, Sánchez-López E, Castro-Torres RD, Verdaguer E, Garcia ML, Olloquequi J, Casadesús G, Beas-Zarate C, Pelegri C, Vilaplana J, Auladell C, Camins A. J Alzheimers Dis; 2018 Dec; 62(3):1223-1240. PubMed ID: 29254093 [Abstract] [Full Text] [Related]
13. Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol. Culmsee C, Junker V, Kremers W, Thal S, Plesnila N, Krieglstein J. Stroke; 2004 May; 35(5):1197-202. PubMed ID: 15060319 [Abstract] [Full Text] [Related]
14. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity. Volbracht C, van Beek J, Zhu C, Blomgren K, Leist M. Eur J Neurosci; 2006 May; 23(10):2611-22. PubMed ID: 16817864 [Abstract] [Full Text] [Related]
15. The mechanism of taurine protection against endoplasmic reticulum stress in an animal stroke model of cerebral artery occlusion and stroke-related conditions in primary neuronal cell culture. Gharibani PM, Modi J, Pan C, Menzie J, Ma Z, Chen PC, Tao R, Prentice H, Wu JY. Adv Exp Med Biol; 2013 May; 776():241-58. PubMed ID: 23392887 [Abstract] [Full Text] [Related]
16. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope. Sonkusare SK, Kaul CL, Ramarao P. Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530 [Abstract] [Full Text] [Related]
17. Excitotoxic neuroprotection and vulnerability with CaMKII inhibition. Ashpole NM, Hudmon A. Mol Cell Neurosci; 2011 Apr; 46(4):720-30. PubMed ID: 21316454 [Abstract] [Full Text] [Related]
18. TRPing into excitotoxic neuronal death. Green MV, West AE. Cell Calcium; 2021 Jan; 93():102331. PubMed ID: 33341523 [Abstract] [Full Text] [Related]
20. The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage. Yoo SJ, Cho B, Lee D, Son G, Lee YB, Soo Han H, Kim E, Moon C, Moon C. Cell Death Dis; 2017 Aug 17; 8(8):e3003. PubMed ID: 28817120 [Abstract] [Full Text] [Related] Page: [Next] [New Search]